You cannot apply for this job anymore (deadline was 29 Aug 2022).
Browse the current job offers or choose an item in the top navigation above.
A 2-year full-time Post-doctoral researcher (1.0 FTE) position supported by the NWA LS-NeoCarE consortium. Your project will focus on the development of anatomically shaped osteochondral implants to treat joint regeneration. You will be performing cutting-edge research in the development and convergence of bioprinting technologies, as well as with novel cell technologies, developed by the consortium partners. You will join the Biofabrication for Translational Regenerative medicine group based at the Department of Orthopeadics of the UMC Utrecht and at the Regenerative Medicine Center Utrecht. You will coordinate your work within an (inter)national network of collaborators, while working in an ambitious, motivated, multi-disciplinairy team of clinicians, veterinarians, physicists, chemists, biologists, and engineers. You will work closely with our consortium partners of the TU Eindhoven and LUMC Leiden. You will co-supervise students during their internships and teaching opportunities will be available, if desired. You will be part of the Graduate School of Life Sciences and will receive training, supervision, and guidance for both your research work and personal/professional development, which provides you an excellent basis for an independent academic career.
The maximum salary for this position (36 hours) is € 4.707 gross per month based on full-time employment.
In addition, we offer an annual benefit of 8.3%, holiday allowance, travel expenses and career opportunities. The terms of employment are in accordance with the Cao University Medical Centers (UMC).
This position is hosted at the Regenerative Medicine Center Utrecht (RMCU) and you will be appointed at the Department of Orthopedics of the UMC Utrecht. Located at the Utrecht Science Park, the RMCU brings together the largest group of researchers in regenerative medicine in the Netherlands. Our outstanding scientists, engineers, clinicians, students, ethicists and staff work closely together to translate scientific and technological discoveries into patient benefit.
The Department of Orthopaedics at the UMC Utrecht is a global leader in the development of novel regenerative technologies, such as 3D (bio)printing, the application of biomaterials and controlled release systems, and novel imaging modalities. The department also initiated the Utrecht Biofabrication Facility, a leading European knowledge center that aims at expediting emerging biofabrication technologies in areas of regenerative medicine, 3D in vitro cell culture models and therapeutic treatments. The department is also involved in the Utrecht Advances in vitro models Hub (U-AIM), taking key steps towards the establishment of the next generation animal-free biomedical research.
We maken het je graag makkelijk, log in voor deze en andere handige functies: